Zhou et al. demonstrated that using SMO-positive pancreatic cancer cells, GDC-0449 could downregulate SHH signaling genes and reverse fibroblast-induced resistance to doxorubicin [91]. Here, SHH is linked to familial pancreatic carcinoma.